LAB Q2 2019 Earnings — Standard BioTools Inc. Revenue & Financial Results | Market Cap Arena

LABStandard BioTools Inc.

$370M

Q2 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$28M+6.7% YoY

Gross Profit

$15M54.5% margin

Operating Income

-$15M-51.9% margin

Net Income

-$14M-48.8% margin

EPS (Diluted)

$-0.20

QoQ Revenue Growth

-6.4%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$284M

Total Liabilities

$111M

Stockholders' Equity

$173M

Cash & Equivalents

$24M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$28M	$26M	+6.7%
Gross Profit	$15M	$14M	+13.1%
Operating Income	-$15M	-$13M	-14.5%
Net Income	-$14M	-$16M	+15.3%

Revenue Segments

Product

$23M45%

Instruments

$12M24%

Consumables

$11M21%

Service

$5M10%

Geographic Segments

Europe

$11M40%

Americas

$11M39%

Asia Pacific

$6M21%